The clinical significance of defining the level of a 2,3-diphosphoglicerin acid contents in erythrocytes of the patients with polycythemia vera
##plugins.themes.bootstrap3.article.main##
Abstract
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Gaidukova S.N., Sivak L.A. 2014. Peculiarities of bone marrow hemopoiesis at erythremic stage of polycytemia vera. Simejnaja medicina. 5: 62–63.
Gaidukova S., Tkachenko O., Bublij J. 2013. Erythrocytosis as a differential diagnostic problem in clinical practice. The Health of Society. 2; 2: 58–67.
Gaidukova S., Tkachenko O., Bublij J. 2016. Free heparin blood plasma of patients with polycythemia vera and incidence of neurological cerebral symptoms. Hematology. Transfusiology. Estern Europe. 2(1): 47–57.
Vojzizkij J.V., Viljashkevich G.B., Shevchenko L.V., Jurchishak I.M. 2015. Metodi diagnostiki Ph-negativnich mieloprolipherativnich sachvorjuvan (istinna policitemija, essencialna trombocytemia, pervinnij mielophibros. Gematologija i perelivanie krovi. 38: 363–364.
Vydyborets S., Kucher O., Sergienko O. 2013. The clinical significance in erythrocyte sedimentation rate index. The Health of Society. 2; 2: 85–92.